International Divergence in Gene Patenting

Annual Review of Genomics and Human Genetics
Dianne NicolGeertrui Van Overwalle

Abstract

This review explores the recent divergence in international patent law relating to genes and associated subject matter. This divergence stems primarily from decisions of the highest courts in the United States and Australia on the eligibility of patent claims relating to the BRCA gene sequences. Patent offices, courts, and policy makers have struggled for many years to clearly articulate the bounds of patent claims on isolated and synthetic DNA and related products and processes, including methods for their use in genetic diagnostics. This review provides context to the current divergence by mapping key events in the gene patent journey from the early 1980s onward in five key jurisdictions: the United States, the member states of the European Patent Convention, Australia, Canada, and China. Early approaches to gene patenting had some commonalities across jurisdictions, which makes exploration of the recent divergence all the more interesting.There is insufficient empirical evidence to date to confidently predict the consequences of this recent divergence. However, it could potentially have a significant effect on local industry and on consumer access.

References

Aug 14, 1992·Science·R S Eisenberg
May 23, 1998·Science·M A Heller, R S Eisenberg
Feb 8, 2002·Nature·Jon F MerzMildred K Cho
Dec 14, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Rebecca S Eisenberg
Dec 14, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Debra G B Leonard
Dec 14, 2002·Academic Medicine : Journal of the Association of American Medical Colleges·Rebecca S Eisenberg, Richard R Nelson
Jan 29, 2003·The Journal of Molecular Diagnostics : JMD·Mildred K ChoJon F Merz
Oct 28, 2005·European Journal of Human Genetics : EJHG·Birgit VerbeureGeertrui Van Overwalle
Sep 12, 2006·Nature Biotechnology·Timothy CaulfieldJohn P Walsh
Mar 28, 2009·Nature·Sibylle GaisserDolores Ibarreta
Oct 10, 2009·Nature Biotechnology·Isabelle HuysGeertrui Van Overwalle
Jul 2, 2010·Annual Review of Genomics and Human Genetics·Robert Cook-Deegan, Christopher Heaney
Aug 11, 2010·Nature Biotechnology·Julia CarboneRobert Cook-Deegan
Nov 15, 2012·European Journal of Human Genetics : EJHG·Robert Cook-DeeganDaniel Vorhaus
May 10, 2013·Nature Biotechnology·Gregory D GraffPhilip G Pardey
May 21, 2013·Prenatal Diagnosis·Ashwin AgarwalSubhashini Chandrasekharan
May 25, 2013·Australian Health Review : a Publication of the Australian Hospital Association·Dianne Nicol, John Liddicoat
Aug 10, 2013·Nature Biotechnology·Gert MatthijsDominique Stoppa-Lyonnet
Oct 10, 2014·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Robert Cook-Deegan, Subhashini Chandrasekharan
Oct 10, 2014·Nature Biotechnology·Wei Li, LiSheng Cai
Nov 8, 2014·Cold Spring Harbor Perspectives in Medicine·Hans-Rainer Jaenichen, Johann Pitz
Apr 8, 2015·Nature Biotechnology·Johnathon LiddicoatDianne Nicol
May 28, 2015·The New England Journal of Medicine·Douglas F EastonWilliam D Foulkes
Oct 8, 2015·Annual Review of Genetics·Jacob S Sherkow, Henry T Greely
Nov 9, 2016·Nature Biotechnology·Mateo AboyCristina Crespo
Sep 13, 2017·Nature Biotechnology·Mateo AboyCristina Crespo

❮ Previous
Next ❯

Citations

Sep 3, 2020·Annual Review of Genomics and Human Genetics·Christi J Guerrini, Jorge L Contreras
Mar 16, 2021·Asian Bioethics Review·Li DuKalina Kamenova

❮ Previous
Next ❯

Software Mentioned

Ariosa
AMP
Mayo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Law and the Biosciences
Rochelle C DreyfussDianne Nicol
IDrugs : the Investigational Drugs Journal
Philip M Webber
Pharmaceutical Patent Analyst
Scott Parker, Ben Hall
© 2022 Meta ULC. All rights reserved